900800-27-3

Usage

General Description

2-Aminomethyl-4-isopropylpyridine is a chemical compound with the molecular formula C11H17N. It is a derivative of pyridine and contains an amino group and an isopropyl group attached to the carbon atoms of the pyridine ring. 2-aminomethyl-4-isopropylpyridine has potential applications in medicinal chemistry, particularly in the development of pharmaceutical drugs. Its structural features make it suitable for use in the design of new compounds with biological activity, such as anti-inflammatory or analgesic properties. Additionally, it may also be used as a building block for the synthesis of other organic compounds with desired properties. Overall, 2-aminomethyl-4-isopropylpyridine is a versatile chemical with potential applications in various fields of chemistry and pharmacology.

Upstream product

• 676136-14-4 6-cyano-4-isopropylpyridine 
• 696-30-0 4-s-propylpyridine 
• 22581-87-9 4-isopropylpyridine 1-oxide 

Relevant academic research and scientific papers

PRODUCTION METHOD OF OPTICALLY ACTIVE SECONDARY ALCOHOL

PROBLEM TO BE SOLVED: To provide a chemical catalytic method allowing efficient production of a corresponding optically active secondary alcohol from an aromatic ketone having a substituent at each of two β-positions in an aromatic ring to the carbonyl site, so that both enantiomers can be separately made. SOLUTION: A production method of optically active secondary alcohol is characterized by reacting a ketone compound such as acetophenone derivatives with hydrogen in the presence of a ruthenium complex catalyst having an optically active diphosphine ligand. COPYRIGHT: (C)2015,JPO&INPIT

(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING

The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)

Macrocyclic Compounds Useful as Bace Inhibitors

The invention relates to novel macrocyclic compounds of the formula (I), in which all of the variables are as defined in the specification, the number of ring atoms included in the macrocyclic ring being 14, 15, 16 or 17, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them.